Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

February 01, 2019; Volume 16,Issue 1

Editorial

  • You have access
    The breakthrough in primary human hepatocytes in vitro expansion
    Mei Feng, Ruirui Kong and Yisheng Pan
    Cancer Biology & Medicine February 2019, 16 (1) 1-3; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0030
  • You have access
    Next-generation sequencing and its clinical application
    Dahui Qin
    Cancer Biology & Medicine February 2019, 16 (1) 4-10; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0055

Review

  • You have access
    Circular RNAs and human glioma
    Jinglei Liu, Kun Zhao, Nunu Huang and Nu Zhang
    Cancer Biology & Medicine February 2019, 16 (1) 11-23; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0425
  • You have access
    Qidong: a crucible for studies on liver cancer etiology and prevention
    Jianguo Chen, Jian Zhu, Gaoren Wang, John D. Groopman and Thomas W. Kensler
    Cancer Biology & Medicine February 2019, 16 (1) 24-37; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0394

Original Article

  • You have access
    The PI3K/Akt/GSK-3β/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility
    Fengjiao Jin, Zhaozhen Wu, Xiao Hu, Jiahui Zhang, Zihe Gao, Xiao Han, Junfang Qin, Chen Li and Yue Wang
    Cancer Biology & Medicine February 2019, 16 (1) 38-54; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0253
  • You have access
    Estrogen and insulin synergistically promote endometrial cancer progression via crosstalk between their receptor signaling pathways
    Wenyan Tian, Fei Teng, Jinping Gao, Chao Gao, Guoyan Liu, Yanfang Zhang, Shizhu Yu, Wei Zhang, Yingmei Wang and Fengxia Xue
    Cancer Biology & Medicine February 2019, 16 (1) 55-70; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0157
  • You have access
    Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
    Yuxiang Wang, Xian Li, Xueling Liu, Yi Chen, Chunhao Yang, Cun Tan, Bobo Wang, Yiming Sun, Xi Zhang, Yinglei Gao, Jian Ding and Linghua Meng
    Cancer Biology & Medicine February 2019, 16 (1) 66-83; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0361
  • You have access
    p53 mutation regulates PKD genes and results in co-occurrence of PKD and tumorigenesis
    Haili Li, Yongjin Zhang, Juhua Dan, Ruoyu Zhou, Cui Li, Rong Li, Xiaoming Wu, Sanjay Kumar Singh, Jeffrey T. Chang, Julun Yang and Ying Luo
    Cancer Biology & Medicine February 2019, 16 (1) 79-102; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0170
  • You have access
    Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma
    Lu Chen, Xiangdong Tian, Wenchen Gong, Bo Sun, Guangtao Li, Dongming Liu, Piao Guo, Yuchao He, Ziye Chen, Yuren Xia, Tianqiang Song and Hua Guo
    Cancer Biology & Medicine February 2019, 16 (1) 89-100; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0077
  • You have access
    STIM1 overexpression in hypoxia microenvironment contributes to pancreatic carcinoma progression
    Jian Wang, Junling Shen, Kaili Zhao, Jinmeng Hu, Jiuxing Dong and Jianwei Sun
    Cancer Biology & Medicine February 2019, 16 (1) 100-108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0304
  • You have access
    Memory stem T cells generated by Wnt signaling from blood of human renal clear cell carcinoma patients
    Cihui Yan, Jingjing Chang, Xinmiao Song, Fan Yan, Wenwen Yu, Yang An, Feng Wei, Lili Yang and Xiubao Ren
    Cancer Biology & Medicine February 2019, 16 (1) 109-124; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0118
  • You have access
    Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients
    Xiangqian Zheng, Chen Peng, Ming Gao, Jingtai Zhi, Xiukun Hou, Jingzhu Zhao, Xi Wei, Jiadong Chi, Dapeng Li and Biyun Qian
    Cancer Biology & Medicine February 2019, 16 (1) 121-130; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0125
  • You have access
    BRAFV600E vs. TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules
    Ya Wu, Ting Xu, Xingyue Cao, Xin Zhao, Hongyan Deng, Jianxiang Wang, Xiao Li, Qing Yao, Xinhua Ye, Meiping Shen and Xiaohong Wu
    Cancer Biology & Medicine February 2019, 16 (1) 131-138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0291
  • You have access
    Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma
    Lijuan Li, Nan Wu, Fangxuan Li, Lingmei Li, Lijuan Wei and Juntian Liu
    Cancer Biology & Medicine February 2019, 16 (1) 139-146; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0035
  • You have access
    Identification of portal vein tumor thrombus with an independent clonal origin in hepatocellular carcinoma via multi-omics data analysis
    Shupeng Liu, Zaixin Zhou, Yin Jia, Jie Xue, Zhiyong Liu, Kai Cheng, Shuqun Cheng and Shanrong Liu
    Cancer Biology & Medicine February 2019, 16 (1) 147-170; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0184
  • You have access
    68Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomy
    Janice S.H. Tan, Charles X.Y. Goh, Yen Sin Koh, Youquan Li, Jeffrey K.L. Tuan, Eu Tiong Chua, Terence W.K. Tan, Michael L.C. Wang, Lui Shiong Lee, Kae Jack Tay, Ravindran Kanesvaran, Chee Keong Toh, Aaron K.T. Tong, Winnie W.C. Lam and Melvin L.K. Chua
    Cancer Biology & Medicine February 2019, 16 (1) 157-166; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0288
  • You have access
    Perioperative rh-endostatin with chemotherapy improves the survival of conventional osteosarcoma patients: a prospective non-randomized controlled study
    Hairong Xu, Zhen Huang, Yuan Li, Qing Zhang, Lin Hao and Xiaohui Niu
    Cancer Biology & Medicine February 2019, 16 (1) 166-172; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0315
  • You have access
    Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210
    Xuelian Chen, Lanying Ma, Xi Wang, Hongnan Mo, Dawei Wu, Bo Lan, Dong Qu, Hongtu Zhang, Jing Huang and Binghe Xu
    Cancer Biology & Medicine February 2019, 16 (1) 173-181; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0172
  • You have access
    Methods of computed tomography screening and management of lung cancer in Tianjin: design of a population-based cohort study
    Yihui Du, Yingru Zhao, Grigory Sidorenkov, Geertruida H. de Bock, Xiaonan Cui, Yubei Huang, Monique D. Dorrius, Mieneke Rook, Harry J. M. Groen, Marjolein A. Heuvelmans, Rozemarijn Vliegenthart, Kexin Chen, Xueqian Xie, Shiyuan Liu, Matthijs Oudkerk and Zhaoxiang Ye
    Cancer Biology & Medicine February 2019, 16 (1) 181-188; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0237

Consensus

  • You have access
    Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology
    Xuchao Zhang, Zhiyong Liang, Shengyue Wang, Shun Lu, Yong Song, Ying Cheng, Jianming Ying, Weiping Liu, Yingyong Hou, Yangqiu Li, Yi Liu, Jun Hou, Xiufeng Liu, Jianyong Shao, Yanhong Tai, Zheng Wang, Li Fu, Hui Li, Xiaojun Zhou, Hua Bai, Mengzhao Wang, You Lu, Jinji Yang, Wenzhao Zhong, Qing Zhou, Xuening Yang, Jie Wang, Cheng Huang, Xiaoqing Liu, Xiaoyan Zhou, Shirong Zhang, Hongxia Tian, Yu Chen, Ruibao Ren, Ning Liao, Chunyan Wu, Zhongzheng Zhu, Hongming Pan, Yanhong Gu, Liwei Wang, Yunpeng Liu, Suzhan Zhang, Tianshu Liu, Gong Chen, Zhimin Shao, Binghe Xu, Qingyuan Zhang, Ruihua Xu, Lin Shen, Yilong Wu and On behalf of Chinese Society of Clinical Oncology (CSCO) Tumor Biomarker Committee
    Cancer Biology & Medicine February 2019, 16 (1) 189-204; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0142
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 16 (1)
Cancer Biology & Medicine
Vol. 16, Issue 1
1 Feb 2019
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorial
  • Review
  • Original Article
  • Consensus

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire